LUNG
Pulmonx Corp

654
Mkt Cap
$98.17M
Volume
740,524.00
52W High
$9.37
52W Low
$1.31
PE Ratio
-1.57
LUNG Fundamentals
Price
$2.22
Prev Close
$2.38
Open
$2.34
50D MA
$1.88
Beta
1.19
Avg. Volume
1.15M
EPS (Annual)
-$1.44
P/B
1.53
Rev/Employee
$287,934.71
Loading...
Loading...
News
all
press releases
Pulmonx (NASDAQ:LUNG) CEO Glendon French III Sells 8,805 Shares
Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) CEO Glendon French III sold 8,805 shares of Pulmonx stock in a transaction dated Monday, December 1st. The shares were sold at an average price of...
MarketBeat·19d ago
News Placeholder
More News
News Placeholder
Insider Selling: Pulmonx (NASDAQ:LUNG) General Counsel Sells 10,278 Shares of Stock
Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) General Counsel David Aaron Lehman sold 10,278 shares of the firm's stock in a transaction on Monday, December 1st. The shares were sold at an...
MarketBeat·19d ago
News Placeholder
Insider Selling: Pulmonx (NASDAQ:LUNG) CEO Sells 8,805 Shares of Stock
Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) CEO Glendon French III sold 8,805 shares of the firm's stock in a transaction dated Monday, December 1st. The shares were sold at an average price...
MarketBeat·19d ago
News Placeholder
Pulmonx Corporation $LUNG Shares Sold by Primecap Management Co. CA
Primecap Management Co. CA trimmed its position in shares of Pulmonx Corporation (NASDAQ:LUNG - Free Report) by 4.6% in the second quarter, according to its most recent filing with the Securities and...
MarketBeat·1mo ago
News Placeholder
Pulmonx (NASDAQ:LUNG) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded Pulmonx from a "sell" rating to a "hold" rating in a report on Sunday...
MarketBeat·1mo ago
News Placeholder
Pulmonx (NASDAQ:LUNG) Receives "Buy" Rating from D. Boral Capital
D. Boral Capital reiterated a "buy" rating and set a $14.00 price target on shares of Pulmonx in a research note on Thursday...
MarketBeat·1mo ago
News Placeholder
Pulmonx (NASDAQ:LUNG) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS
Pulmonx (NASDAQ:LUNG - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.40) by $0.06. The...
MarketBeat·1mo ago
News Placeholder
Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates
Pulmonx (LUNG) delivered earnings and revenue surprises of +15.00% and +4.10%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Pulmonx's Earnings: A Preview
read more...
Benzinga·1mo ago
News Placeholder
Pulmonx Corporation (NASDAQ:LUNG) Receives Average Recommendation of "Hold" from Analysts
Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) has received an average recommendation of "Hold" from the ten brokerages that are presently covering the company, MarketBeat.com reports. One...
MarketBeat·2mo ago
<
1
2
...
>

Latest LUNG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.